PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.\', \'Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.\', \'Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.\', \'Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.\', \'Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, Utah, USA.\', \'Division of Microbiology and Immunology, University of Utah School of Medicine, Salt Lake City, Utah, USA.\', \'Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/cid/ciab646
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 34302458
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all